TRENTON, N.J. (AP) — Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. After years of frequent list price hikes, many drugmakers are showing some restraint, according to the analysis of drug prices provided by health information firm Elsevier. In the first seven months of 2019, drugmakers raised list prices for brand-name prescription medicines by a median of 5%.Read more on NewsOK.com